Industry leaders explored the risks and benefits of adopting a China Plus One strategy at Advamed’s The MedTech Conference in ...

On Tuesday, Johnson & Johnson (NYSE:JNJ) reported a third-quarter adjusted EPS of $2.42, down 9.0% year-over-year, beating ...

Abbott Laboratories raised its 2024 earnings guidance after strong Q3 results, driven by growth in Pharma and MedTech ...

"Make sure that when you build your products, you're thinking about it as an open platform," Nvidia's Mostafa Toloui said ...

Here are eight key developments from spine and orthopedic devicemakers since Oct. 9. 1. Johnson & Johnson MedTech began the ...

JNJ's 3Q earnings expected to be $2.21 EPS and $22.16B revenue. Recent acquisitions and drug trials impacting stock's ...

Authors:Kirk Harmon, Vice President & GM, Contract Sales Organization, IQVIAJavier “Jave” Castillo, R.Ph, Vice President, CSO ...

Employees at the 10 largest medtech employers in the world are excited about culture but are still frustrated by corporate ...

TORONTO—NYU Langone Health has tapped Philips to help take its pathology program fully digital—including translating its ...

Stryker's 8% CAGR revenue growth over the past 12 years was driven by organic growth and acquisitions. Learn more about SYK ...

Jefferies analyst Matthew Taylor maintained a Hold rating on Abbott Laboratories (ABT – Research Report) today and set a price target of ...